GlassScriptPhysician profile
Dawn M Scott
NPI 1629030978
$1,254.77
in general payments reported to CMS, 2019-2025
14 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $401 · 2022: $220 · 2023: $191 · 2024: $169 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $548.57 | 2021-2025 | |
| Novo Nordisk INC | $281.81 | 2021-2025 | Rybelsus, Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.85 | 2021 | |
| Lilly USA, LLC | $57.69 | 2021-2025 | Mounjaro |
| Teva Pharmaceuticals USA, INC. | $45.95 | 2021 | |
| Sanofi-Aventis U.S. LLC | $42.32 | 2022 | |
| Glaxosmithkline, LLC. | $33.04 | 2023-2024 | Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $32.43 | 2021 | |
| Pfizer INC. | $31.91 | 2021 | |
| Abbott Laboratories | $24.98 | 2024 | Infinity |
| Ars Pharmaceuticals Operations, INC. | $20.87 | 2025 | Neffy |
| Ani Pharmaceuticals, INC. | $17.59 | 2025 | Purified Cortrophin Gel |
| Ibsa Pharma INC. | $12.57 | 2021 | |
| Mallinckrodt Hospital Products INC. | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.